ERK activation causes epilepsy by stimulating NMDA receptor activity
Abdolrahman S Nateri1, Gennadij Raivich, Christine Gebhardt
1Mammalian Genetics Laboratory, Cancer Research UK, London Research Institute, Lincoln's Inn Fields Laboratories, London, UK.
This study reveals how ERK pathway activation in neurons leads to epilepsy. It highlights the roles of NMDA receptors and ephrinB2 in this process, offering new insights into epileptogenesis.
Area of Science:
- Neuroscience
- Molecular Biology
- Signaling Pathways
Background:
- The ERK (extracellular signal-regulated kinase) MAPK (mitogen-activated protein kinase) pathway is crucial for cell signaling.
- Understanding ERK's role in neuronal function is vital for neurological research.
Purpose of the Study:
- To investigate the function of ERK in neurons.
- To elucidate the molecular mechanisms underlying ERK-induced epilepsy.
Main Methods:
- Conditional expression of constitutively active MEK1 (caMEK1) in the murine brain.
- Analysis of ERK activation, downstream signaling molecules (eIF4E, NR2B, CREB, ephrinB2), and synaptic function.
- Pharmacological inhibition of NMDA receptor function and conditional inactivation of ephrinB2.
Main Results:
- caMEK1 expression activated ERK, leading to spontaneous epileptic seizures.
- ERK activation increased phosphorylation of eIF4E and NR2B levels.
- NR2B inhibition impaired synaptic facilitation and abrogated epilepsy; ephrinB2 inactivation reduced seizure frequency.
Conclusions:
- ERK pathway activation in neurons contributes to epileptogenesis.
- A signaling cascade involving MAP kinase, Eph/Ephrin, and NMDA receptors underlies epilepsy.
- This pathway represents a potential therapeutic target for seizure disorders.
More Related Videos
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
09:29Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
Published on: August 17, 2021
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
